Cardiometabolic Biomarkers in Young Black Girls: Relations to Body Fatness and Aerobic Fitness, and Effects of a Randomized Physical Activity Trial
Table 3
Cardiometabolic biomarkers at baseline and at 10 months for the intervention and control groups with all intervention subjects included regardless of attendance at the PA sessions (unadjusted mean [SD]).
Variable
Baseline
10 Months
Adjusted change (SE)*
value
Intervention
Control
Intervention
Control
Insulin, pmol/L†
119.4 (84.8)
101.4 (59.9)
130.6 (79.7)
122.4 (57.1)
−3.6 (8.9)
0.69
Glucose, mmol/L†
4.89 (0.39)
4.91 (0.43)
4.85 (0.37)
4.89 (0.38)
−0.03 (0.06)
0.63
SBP, mm Hg‡
104.1 (7.5)
102.4 (9.1)
105.1 (8.3)
103.8 (7.6)
0.5 (1.0)
0.64
DBP, mm Hg‡
59.0 (5.6)
59.5 (5.7)
58.3 (6.5)
58.8 (5.4)
−0.3 (0.8)
0.72
HR, bpm‡
79.6 (9.2)
79.8 (8.9)
74.1 (8.9)
76.9 (8.3)
−2.7 (1.1)
0.01
TC, mmol/L†
4.18 (0.83)
4.15 (0.70)
4.01 (0.74)
4.15 (0.67)
−0.15 (0.09)
0.08
TG, mmol/L†
0.66 (0.30)
0.63 (0.30)
0.77 (0.37)
0.71 (0.32)
0.04 (0.05)
0.46
HDLC, mmol/L†
1.34 (0.32)
1.29 (0.28)
1.36 (0.31)
1.34 (0.31)
−0.01 (0.04)
0.73
LDLC, mmol/L†
2.67 (0.85)
2.67 (0.69)
2.47 (0.70)
2.67 (0.75)
−0.20 (0.10)
0.04
LP(a), mg/dL†
45.5 (30.1)
50.6 (42.8)
47.8 (31.1)
57.3 (48.1)
−4.48 (3.59)
0.21
LDL size, nm†
26.1 (0.69)
26.2 (0.69)
25.7 (0.82)
25.8 (0.72)
−0.09 (0.14)
0.50
%HDL2†
36.9 (20.3)
36.7 (20.2)
36.1 (20.3)
35.8 (17.6)
0.17 (3.30)
0.96
ApoA1, mg/dL†
132.8 (32.3)
124.3 (22.7)
126.2 (22.1)
125.3 (20.7)
−1.31 (3.68)
0.72
ApoB, mg/dL†
77.6 (29.9)
77.3 (26.1)
71.9 (26.6)
74.1 (21.9)
−2.3 (4.3)
0.60
ApoCIII, ng/mL†
12.0 (3.8)
11.4 (3.9)
11.1 (4.2)
11.5 (4.3)
−0.62 (0.69)
0.37
ApoE, ng/mL†
5.26 (1.49)
5.03 (1.75)
5.04 (1.56)
4.78 (1.56)
0.09 (0.20)
0.66
CRP, ng/mL†
757.3 (1571.0)
694.2 (883.6)
597.9 (1333.7)
795.8 (1120.5)
−245.8 (145.2)
0.09
Fibrinogen, mg/dL†
2.72 (0.51)
2.77 (0.55)
2.89 (0.50)
2.91 (0.60)
0.02 (0.08)
0.83
SD: standard deviation; SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; TC: total cholesterol; TG: triglycerides; HDLC: high-density lipoprotein cholesterol; LDLC: low-density lipoprotein cholesterol; Lp(a): lipoprotein(a); VLDL: very low-density lipoprotein; Apo: apolipoprotein; CRP: C-reactive protein.
*Change estimates and standard errors (SE) are the differences between intervention and control groups adjusted for age and baseline value. †Intervention , Control . ‡Intervention , Control .
